Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections.
Nanoscale Adv. 2021 May 17;3(14):4005-4018. doi: 10.1039/d1na00205h. eCollection 2021 Jul 13.
Nanoscale Adv. 2021.
PMID: 36132845
Free PMC article.
Review.
Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions.
Sabuj MZR, Rashid MA, Dargaville TR, Islam N.
Sabuj MZR, et al.
Pharmaceuticals (Basel). 2022 Oct 2;15(10):1223. doi: 10.3390/ph15101223.
Pharmaceuticals (Basel). 2022.
PMID: 36297335
Free PMC article.
Item in Clipboard
Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide.
Sabuj MZR, Huygens F, Spann KM, Tarique AA, Dargaville TR, Will G, Wahab MA, Islam N.
Sabuj MZR, et al.
Int J Mol Sci. 2023 Feb 25;24(5):4532. doi: 10.3390/ijms24054532.
Int J Mol Sci. 2023.
PMID: 36901963
Free PMC article.
Item in Clipboard
Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections.
Sabuj MZR, Dargaville TR, Nissen L, Islam N.
Sabuj MZR, et al.
PLoS One. 2021 Dec 23;16(12):e0261720. doi: 10.1371/journal.pone.0261720. eCollection 2021.
PLoS One. 2021.
PMID: 34941946
Free PMC article.
Item in Clipboard
Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection.
Rashid MA, Muneer S, Mendhi J, Sabuj MZR, Alhamhoom Y, Xiao Y, Wang T, Izake EL, Islam N.
Rashid MA, et al. Among authors: sabuj mzr.
Int J Pharm. 2021 Oct 25;608:121122. doi: 10.1016/j.ijpharm.2021.121122. Epub 2021 Sep 21.
Int J Pharm. 2021.
PMID: 34560207
Free PMC article.
Item in Clipboard
Cite
Cite